Anti-redness active agent and cosmetic compositions comprising same
The present application relates to a cosmetic method for preventing and/or treating skin redness, characterized in that a composition comprising arabinogalactan is administered to a person who may form or who is displaying redness. This cosmetic composition can be administered topically or orally.
1. A method for treating a skin redness due to vascular disorders, comprising administering a cosmetic composition comprising an effective amount of a synergistic combination of arabinogalactan and lupin peptides to a person having redness, wherein the arabinogalactan is in a concentration between 0.01% and 10% by weight and the lupin peptides are in a concentration of between 0.01% and 10% by weight in the composition.
2. The method of claim 1 , wherein said composition is administered topically.
3. The method of claim 1 , wherein said composition is administered orally.
4. The method of claim 1 , wherein the arabinogalactan is extracted from larch.
5. The method of claim 1 , wherein said composition includes at least one other anti-redness agent selected from the group consisting of: permethol, genistein, esculoside, dextran sulfate, hesperidin methyl chalcone, retinoids, licochalcone, oxymetazoline, kinetin, licorice extract, vitamin P-like, butcher's broom extract, Sophora japonica, Hamamelis extract, Ruscus , antibiotics, polyphenols including tannins, phenolic acids, anthocyans, procyanidols, flavonoids, extracts of green tea, red berries, cocoa, grape, Passiflora incarnata , and Citrus.
6. The method of claim 1 , wherein said composition comprises 0.2% of arabinogalactan.
7. The method of claim 1 , wherein said composition comprises 0.2% of lupin peptides.
8. The method of claim 1 , wherein said skin redness is due to an outbreak of redness on the skin.
9. A method for treating rosacea comprising administering an oral or topical composition comprising an effective amount of a synergistic combination of arabinogalactan and lupin peptides, wherein the arabinogalactan is in a concentration between 0.01% and 10% by weight and the lupin peptides are in a concentration of between 0.01% and 10% in the composition.